首頁 > 市場調查報告書 > 製藥

自體免疫疾病

市場調查報告書

商品編碼

1820660

全球類風濕性關節炎藥物市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Rheumatoid Arthritis Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年07月01日 | 出版商:

Value Market Research | 英文 107 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球類風濕性關節炎藥物市場預計將經歷顯著擴張，預計 2025 年至 2033 年的年複合成長率(CAGR) 為 6.17%。根據市場分析，預計到 2033 年底市場規模將達到 424.3 億美元，高於 2024 年的 247.6 億美元。

全球類風濕關節炎 (RA) 藥物市場預計將穩定成長，這得益於自體免疫疾病盛行率的上升以及標靶生物療法的進步。改善病情的抗風濕藥物 (DMARD)，包括生物製劑和 Janus 激酶 (JAK) 抑制劑，正在改善疾病管理和患者生活品質。未來的發展將著重於個人化醫療、新型藥物輸送系統和聯合療法。

此外，醫療基礎設施的不斷擴展和認知項目的不斷推進，正在拓寬患者用藥管道，尤其是在新興市場。監管部門的核准和生物相似藥的引入正在影響市場動態。生物標記研究和數位健康工具的進步正在增強治療監測。隨著類風濕性關節炎治療的發展，藥物市場將持續創新，提供更安全、更有效、更方便的療法。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 8 章：類風濕性關節炎藥物公司的競爭格局

類風濕性關節炎藥物市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第9章：公司簡介

頂級公司市佔率分析
市場集中度
AbbVie Inc.

公司概況
公司收入
產品
最新動態

Johnson & Johnson Innovative Medicine

公司概況
公司收入
產品
最新動態

Amgen Inc.

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Novartis AG

公司概況
公司收入
產品
最新動態

Sanofi SA

公司概況
公司收入
產品
最新動態

F. Hoffmann-La Roche Ltd.

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

Bristol-Myers Squibb Company

公司概況
公司收入
產品
最新動態

Eli Lilly And Company

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

簡介目錄圖表

Product Code: VMR112111983

Global Rheumatoid Arthritis Drugs Market is anticipated to experience remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 6.17% from 2025 to 2033. According to the market analysis, the market size is forecasted to reach USD 42.43 Billion by the end of 2033, up from USD 24.76 Billion in 2024.

The global rheumatoid arthritis (RA) drugs market is set for steady growth driven by increasing prevalence of autoimmune disorders and advancements in targeted biologic therapies. Disease-modifying antirheumatic drugs (DMARDs), including biologics and Janus kinase (JAK) inhibitors, are improving disease management and patient quality of life. Future developments will focus on personalized medicine, novel drug delivery systems, and combination therapies.

Moreover, expanding healthcare infrastructure and awareness programs are broadening patient access, especially in emerging markets. Regulatory approvals and biosimilar introductions are influencing market dynamics. Advances in biomarker research and digital health tools are enhancing treatment monitoring. As RA care evolves, the drugs market will continue to innovate, delivering safer, more effective, and accessible therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Rheumatoid Arthritis Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Type

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Disease Modifying Anti-rheumatic Drugs (DMARDs)
Biologic Response Modifiers (Biologics)

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
List of Companies Profiled in the report
AbbVie Inc., Johnson & Johnson Innovative Medicine, Amgen Inc., Pfizer Inc., Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bristol-Myers Squibb Company, Eli Lilly and Company

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. RHEUMATOID ARTHRITIS DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Type
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL RHEUMATOID ARTHRITIS DRUGS MARKET ANALYSIS BY DRUG TYPE

5.1. Overview By Drug Type
5.2. Historical and Forecast Data Analysis By Drug Type
5.3. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Historic and Forecast Sales By Regions
5.4. Corticosteroids Historic and Forecast Sales By Regions
5.5. Disease Modifying Anti-rheumatic Drugs (DMARDs) Historic and Forecast Sales By Regions
5.6. Biologic Response Modifiers (Biologics) Historic and Forecast Sales By Regions

6. GLOBAL RHEUMATOID ARTHRITIS DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospital Pharmacy Historic and Forecast Sales By Regions
6.4. Retail Pharmacy Historic and Forecast Sales By Regions
6.5. Online Pharmacy Historic and Forecast Sales By Regions

7. GLOBAL RHEUMATOID ARTHRITIS DRUGS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE RHEUMATOID ARTHRITIS DRUGS COMPANIES

8.1. Rheumatoid Arthritis Drugs Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF RHEUMATOID ARTHRITIS DRUGS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. AbbVie Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Johnson & Johnson Innovative Medicine
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Amgen Inc.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Pfizer Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Novartis AG
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Sanofi S.A.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. F. Hoffmann-La Roche Ltd.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Merck & Co. Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Bristol-Myers Squibb Company
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Eli Lilly And Company
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Drug Type (USD MN)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Market Sales By Geography (USD MN)
Corticosteroids Market Sales By Geography (USD MN)
Disease Modifying Anti-rheumatic Drugs (DMARDs) Market Sales By Geography (USD MN)
Biologic Response Modifiers (Biologics) Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Hospital Pharmacy Market Sales By Geography (USD MN)
Retail Pharmacy Market Sales By Geography (USD MN)
Online Pharmacy Market Sales By Geography (USD MN)
Global Rheumatoid Arthritis Drugs Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Rheumatoid Arthritis Drugs Report
Market Research Process
Market Research Methodology
Global Rheumatoid Arthritis Drugs Market Size, By Regions (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Drug Type
Market Attractiveness Analysis By Distribution Channel
Market Attractiveness Analysis By Regions
Value Chain Analysis
Global Market Analysis By Drug Type (USD MN)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Market Sales By Geography (USD MN)
Corticosteroids Market Sales By Geography (USD MN)
Disease Modifying Anti-rheumatic Drugs (DMARDs) Market Sales By Geography (USD MN)
Biologic Response Modifiers (Biologics) Market Sales By Geography (USD MN)
Global Market Analysis By Distribution Channel (USD MN)
Hospital Pharmacy Market Sales By Geography (USD MN)
Retail Pharmacy Market Sales By Geography (USD MN)
Online Pharmacy Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis